Scalp-ear-nipple syndrome, also known as Finlay-Markes syndrome, is a rare genetic disorder characterized by congenital abnormalities of the scalp, ears, and nipples. Patients with this syndrome have dysplasia or hypoplasia of the ears, as well as abnormal changes in the structure of the scalp, including alopecia and abnormal hair growth. In some cases, there may be abnormalities in the development of the mammary glands and nipples, which may manifest as underdevelopment or absence of them. This syndrome belongs to a group of congenital malformations and is associated with genetic mutations affecting the processes of embryonic development of tissues of ectodermal origin.
History of the disease and interesting historical facts
Finlay-Markes syndrome was first described in 1982 by two researchers, Finley and Marx, who studied several cases of congenital anomalies united by common features of lesions of the scalp, ears and nipples. Subsequently, this syndrome came to be considered as one of the rare examples of developmental disorders affecting several anatomical structures simultaneously, developing from a single germinal layer. Although the number of registered cases remains extremely low, this syndrome is interesting from the point of view of studying the processes of embryogenesis and morphogenesis of the skin and epithelial structures.
Epidemiology
Epidemiological data on scalp-ear-nipple syndrome are extremely limited due to its rarity. Currently, less than 100 cases of this disorder have been described in the medical literature. The syndrome occurs with equal frequency in men and women and does not have a pronounced geographic or ethnic predisposition. The main age group of patients are newborns and children in whom congenital changes are detected during physical examination.
Genetic predisposition to this disease
Finlay-Markes syndrome is considered a genetic disorder, although the exact mechanism of its inheritance is not fully understood. It is assumed that the disease is associated with mutations in genes that control the embryonic development of tissues of ectodermal origin, but specific genes or loci have not yet been identified. In some cases, the possibility of an autosomal dominant type of inheritance is discussed, but there is no confirmed data on this. Genetic studies are needed to better understand the pathogenesis of the disease and to develop methods for prenatal diagnosis.
Risk factors for the development of this disease
To date, no specific risk factors have been identified that could contribute to the development of scalp-ear-nipple syndrome. Since the disease is congenital, the main risk factors are genetic mutations that affect tissue morphogenesis processes. There is no data on the influence of the environment, infections, or chemical exposures on the incidence of the syndrome.
Diagnosis of this disease
Diagnosis of Finlay-Markes syndrome is based on clinical examination and identification of characteristic congenital anomalies. The main symptoms include:
- Hypoplasia or dysplasia of the auricles.
- Alopecia or abnormal hair growth on the scalp.
- Hypoplasia or absence of nipples and mammary glands.
Imaging tests such as ultrasound to evaluate the mammary glands may be used to confirm the diagnosis. Differential diagnosis includes other syndromes involving abnormal development of the auricles such as Goldenhar syndrome and conditions affecting the skin and hair such as hypotrichosis.
Treatment
Treatment of Finlay-Markes syndrome is primarily symptomatic, aimed at correcting congenital anomalies. Surgical treatment is used to reconstruct the auricles and correct scalp deformities. In the absence of mammary glands or nipples in women, plastic surgery for aesthetic correction is possible. In some cases, hormonal therapy is prescribed to stimulate the development of mammary glands, but its effectiveness is limited. Patients may also receive psychoemotional support due to cosmetic defects that may affect the quality of life.
List of medications used to treat this disease
There are no direct medications for the treatment of Finlay-Markes syndrome, but the following drugs may be used to correct concomitant conditions:
— Estrogens (for hypoplasia of the mammary glands in women).
— Anti-inflammatory drugs (for complications after surgery).
— Antibiotics (in the presence of skin infections after surgical correction).
Disease monitoring
Monitoring of patients with Finlay-Markes syndrome includes regular examinations to assess the condition of the skin, ears, and mammary glands. In case of surgical intervention, it is necessary to monitor tissue healing and prevent infectious complications. The prognosis for patients is generally favorable, since the disease does not affect life expectancy, but repeated surgical interventions may be required to improve the cosmetic result. Complications in the form of chronic infections or cicatricial changes are rare.
Age-related features of the disease
Finlay-Markes syndrome manifests itself from birth, and the main clinical signs remain unchanged throughout life. In children, anomalies may increase as they grow, which requires monitoring and, if necessary, surgical correction at an older age. In adult patients, treatment is usually cosmetic. With age, psychoemotional consequences may develop due to visible external defects, which requires psychological support.
Questions and Answers
- How is Finlay-Markes syndrome diagnosed? Diagnosis is based on clinical examination and identification of congenital anomalies of the ears, scalp, and nipples. Additional imaging techniques may also be used.
- Does Finlay-Markes syndrome affect life expectancy? The syndrome does not affect life expectancy, but may require surgical correction to improve quality of life.
- Can Finlay-Markes syndrome be prevented? Since the disease is genetic, its development cannot be prevented. However, prenatal diagnostics can help in early detection.
- What treatments are used for Finlay-Markes syndrome? The main treatment methods include surgical correction of ear, scalp and nipple deformities. Hormonal therapy is also possible in women with breast hypoplasia.
- Is Finlay-Markes syndrome inherited? Currently, the exact mechanism of inheritance is unknown, but autosomal dominant inheritance is suspected in some cases.
